Company Focus

argenx

Latest argenx News

Unnatural Products inks deal with argenx
Biotechnology
California biotech Unnatural Products (UNP) announced a strategic multi-target research collaboration with Dutch immunology specialist argenx to discover and develop oral macrocyclic peptide drugs targeting traditionally “undruggable,” disease targets.   2 July 2025


Insights

Company Spotlight

Latest News & Features of interest to argenx

Latest Relevant Ones To Watch News

US pharma major AbbVie announced it plan to acquire Capstan Therapeutics, along with its autoimmune disease candidate CPTX2309, for up to $2.1 billion. Organon posted disappointing mid-stage trial results for its investigational endometriosis pain drug, OG-6219. Also of note last week, the US Food and drug Administration (FDA) granted accelerated approval for Regeneron’s multiple myeloma drug Lynozyfic.   6 July 2025

More in M&A >


Relevant Ones to Watch Companies

Reset all filters
Refine Search